Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Harvard Business School
Colorcon
Baxter
Moodys

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

PERIKABIVEN IN PLASTIC CONTAINER Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Perikabiven In Plastic Container, and what generic alternatives are available?

Perikabiven In Plastic Container is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in PERIKABIVEN IN PLASTIC CONTAINER is amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil. There are three hundred and fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil profile page.

Summary for PERIKABIVEN IN PLASTIC CONTAINER
Drug patent expirations by year for PERIKABIVEN IN PLASTIC CONTAINER
Anatomical Therapeutic Chemical (ATC) Classes for PERIKABIVEN IN PLASTIC CONTAINER
A06AD Osmotically acting laxatives
A06A DRUGS FOR CONSTIPATION
A06 DRUGS FOR CONSTIPATION
A Alimentary tract and metabolism
A06AG Enemas
A06A DRUGS FOR CONSTIPATION
A06 DRUGS FOR CONSTIPATION
A Alimentary tract and metabolism
A12AA Calcium
A12A CALCIUM
A12 MINERAL SUPPLEMENTS
A Alimentary tract and metabolism
A12BA Potassium
A12B POTASSIUM
A12 MINERAL SUPPLEMENTS
A Alimentary tract and metabolism
A12CC Magnesium
A12C OTHER MINERAL SUPPLEMENTS
A12 MINERAL SUPPLEMENTS
A Alimentary tract and metabolism
B05BA Solutions for parenteral nutrition
B05B I.V. SOLUTIONS
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B Blood and blood forming organs
B05XA Electrolyte solutions
B05X I.V. SOLUTION ADDITIVES
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B Blood and blood forming organs
B05XA Electrolyte solutions
B05X I.V. SOLUTION ADDITIVES
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B Blood and blood forming organs
B05XA Electrolyte solutions
B05X I.V. SOLUTION ADDITIVES
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B Blood and blood forming organs
B05XA Electrolyte solutions
B05X I.V. SOLUTION ADDITIVES
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B Blood and blood forming organs
B05XA Electrolyte solutions
B05X I.V. SOLUTION ADDITIVES
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B Blood and blood forming organs
D11AX Other dermatologicals
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D Dermatologicals
G04BA Acidifiers
G04B UROLOGICALS
G04 UROLOGICALS
G Genito-urinary system and sex hormones
V04CC Tests for bile duct patency
V04C OTHER DIAGNOSTIC AGENTS
V04 DIAGNOSTIC AGENTS
V Various

US Patents and Regulatory Information for PERIKABIVEN IN PLASTIC CONTAINER

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Moodys
Harvard Business School
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.